Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Capitalization 2.13B P/E ratio 2024 *
38.8x
P/E ratio 2025 * 28.3x
Enterprise value 1.88B EV / Sales 2024 *
1.6x
EV / Sales 2025 * 1.27x
Free-Float
79.88%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.51%
1 week+0.21%
Current month+0.21%
1 month+8.93%
3 months-14.71%
6 months-33.67%
Current year-36.69%
More quotes
1 week
22.81
Extreme 22.81
24.21
1 month
20.47
Extreme 20.47
24.22
Current year
19.60
Extreme 19.6
42.08
1 year
19.60
Extreme 19.6
42.08
3 years
19.60
Extreme 19.6
68.32
5 years
13.29
Extreme 13.29
68.32
10 years
13.29
Extreme 13.29
68.32
More quotes
Director TitleAgeSince
Chief Executive Officer 56 16-12-31
President 47 21-02-28
Director of Finance/CFO 58 19-04-30
Manager TitleAgeSince
Director/Board Member 67 10-04-30
Director/Board Member 67 15-02-28
Chairman 64 16-12-15
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.51%+0.21%-35.17%-59.57%2.13B
-0.47%+0.66%+23.57%+43.31%549B
+0.32%-2.38%+21.15%+46.37%126B
+1.17%-1.16%+27.05%+67.15%99.97B
-3.94%-3.02%-26.50%-17.59%41.39B
+0.01%-10.14%+8.30%+14.33%37.26B
-1.15%-7.45%+1.01%+25.13%18.97B
-0.95%+4.44%+81.66%-48.61%1.8B
0.00%-4.56%+100.00%-73.04%1.25B
Average -0.39%-2.60%+22.34%-0.28% 97.49B
Weighted average by Cap. -0.32%-0.79%+20.21%+41.37%
See all sector performances
2024 *2025 *
Net sales 1.17B 1.33B
Net income 59.9M 80.14M
Net Debt -249M -428M
More financial data * Estimated data
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
565
Related indices
More about the company
Date Price Change Volume
24-09-09 23.54 $ +1.51% 2,017,576
24-09-06 23.19 $ -2.11% 1,638,784
24-09-05 23.69 $ -0.42% 1,377,387
24-09-04 23.79 $ +0.85% 1,775,061

Delayed Quote Nasdaq, September 09, 2024 at 04:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
23.54USD
Average target price
30.22USD
Spread / Average Target
+28.39%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW